Serotonin receptors: their key role in drugs to treat schizophrenia.

By H. Meltzer, Zhu Li, Y. Kaneda, J. Ichikawa. Progress in Neuro-psychopharmacology and Biological Psychiatry, 2003

800 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Molecular Biology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/e6530d80931b2308133bd42f6028367647107174

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

1. J. Volavka
2. Herbert M. Lachman
3. Robert M. Bilder
4. Anthony A. Grace

In Molecular Biology

1. Anthony A. Grace

In Psychiatry and Mental health

1. Anthony A. Grace

Citations in the corpus

• Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. (2007, background): “This has led to the suggestion that the therapeutic properties of atypical antipsychotic drugs may be related to 5-HT1A receptor agonism alone or after combination with D2 receptor antagonism (Millan, 2000; Meltzer et al., 2003).”
• The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes (2004, background): “…to increase medial prefrontal DA release, and these mechanisms have been proposed as possible routes for cognitive enhancing properties of multiple atypical antipsychotic agents including clozapine, risperidone, olanzapine, quetiapine, and ziprasidone (Ichikawa et al, 2001; Meltzer et al, 2003).”